These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8197967)

  • 1. Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction.
    Kettunen RV; Leppäluoto J; Jounela A; Vuolteenaho O
    Am Heart J; 1994 Jun; 127(6):1449-55. PubMed ID: 8197967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between serial changes in left-sided heart chambers and atrial natriuretic peptide and N-terminal pro atrial natriuretic peptide after a first myocardial infarction. An echocardiographic study.
    Svanegaard J; Johansen JB; Klitgaard NA; Thayssen P; Haghfelt T
    Scand Cardiovasc J; 1999; 33(6):355-61. PubMed ID: 10622548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
    Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction.
    Uusimaa P; Ruskoaho H; Vuolteenaho O; Niemelä M; Lumme J; Ikäheimo M; Jounela A; Peuhkurinen K
    Int J Cardiol; 1999 Apr; 69(1):5-14. PubMed ID: 10362366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of Nt-proANP and C-ANP.
    McDowell G; Patterson C; Maguire S; Shaw C; Nicholls DP; Hall C
    Eur J Clin Invest; 2002 Aug; 32(8):545-8. PubMed ID: 12190952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.
    van der Vekens N; Decloedt A; de Clercq D; Ven S; Sys S; van Loon G
    Equine Vet J; 2016 Jan; 48(1):15-20. PubMed ID: 25257480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
    Ala-Kopsala M; Magga J; Peuhkurinen K; Leipälä J; Ruskoaho H; Leppäluoto J; Vuolteenaho O
    Clin Chem; 2004 Sep; 50(9):1576-88. PubMed ID: 15265819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
    Ikeda N; Yasu T; Nishikimi T; Nakamura T; Kubo N; Kawakami M; Momomura S; Saito M
    Regul Pept; 2007 Jun; 141(1-3):154-8. PubMed ID: 17292492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
    Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
    Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial plasma ANP and NH2-terminal proANP during right atrial pressure increase in humans.
    Arjamaa O; Karlqvist K; Vainionpää V; Leppäluoto J; Vuolteenaho O
    Acta Physiol Scand; 1996 Aug; 157(4):481-5. PubMed ID: 8869731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias.
    Brueckmann M; Bertsch T; Hoffmann U; Lang S; Kaden JJ; Wolpert C; Huhle G; Borggrefe M; Haase KK
    Clin Chem Lab Med; 2004; 42(8):896-902. PubMed ID: 15387439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase.
    Phillips PA; Sasadeus J; Hodsman GP; Horowitz J; Saltups A; Johnston CI
    Br Heart J; 1989 Feb; 61(2):139-43. PubMed ID: 2522310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal proatrial natriuretic peptide in angina pectoris: impact of revascularization by angioplasty.
    Klinge R; Jørgensen B; Thaulow E; Sirnes PA; Hall C
    Int J Cardiol; 1999 Jan; 68(1):1-8. PubMed ID: 10077394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure.
    Azizi C; Maistre G; Kalotka H; Isnard R; Barthélemy C; Masson F; Pham P; Pousset F; Eurin J; Lechat P; Komajda M; Carayon A
    J Endocrinol; 1996 Jan; 148(1):51-7. PubMed ID: 8568471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.